The Rett Syndrome Research Trust (RSRT) was formed recently to explore the development and treatment of the rare and extremely debilitating childhood disorder Rett Syndrome and related MECP2 disorders. RSRT is formed to fund drug therapies for Rett which may provide treatments for related autism and schizophrenia disorders. To date, Rett Syndrome has no effective drug therapy. However, mouse research seem to indicate the horrendous disorder may be reversible.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
Mutations in the methyl CpG binding protein 2 gene (MECP2) are the cause of the devastating childhood neurological disorder Rett Syndrome. Despite intense efforts spanning several decades the precise function of MECP2 has ...
Mar 11, 2015
0
47
The concept behind gene therapy is simple: deliver a healthy gene to compensate for one that is mutated. New research published today in the Journal of Neuroscience suggests this approach may eventually be a feasible option ...
Aug 20, 2013
0
0
Statins, a class of cholesterol-lowering drugs found in millions of medicine cabinets, may help treat Rett Syndrome, according to a study published today in Nature Genetics. The Rett Syndrome Research Trust (RSRT) funded ...
Jul 29, 2013
0
0
(Medical Xpress)—Rett Syndrome is a neurological disorder that affects about 1 in 10,000 girls. Back in 1992, University of Edinburgh researcher Adrian Bird discovered that the protein, MeCP2, plays a major role in the ...
A paper published online today in Nature describes the results of using bone marrow transplant (BMT) to replace faulty immune system cells in models of Rett Syndrome. The procedure arrested many severe symptoms of the childhood ...
Mar 18, 2012
0
0
A paper published online today in Nature reveals that glia play a key role in preventing the progression of the most prominent Rett Syndrome symptoms displayed by mouse models of the disease: lethality, irregular breathing ...
Jun 29, 2011
0
0
